Back

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

💰 Gold Isn't Always Golden: A Look at Past Corrections in INR 🇮🇳 Gold has long been considered a safe haven, but even the most reliable assets see their fair share of corrections. 📉 Here's a quick look at some major dips in gold prices in India o

I came across an interesting PE business model by Cranemere Group. They operate similarly to a 'mini-Berkshire Hathaway'. Traditional Private Equity (PE) Model i). Closed-end funds with a fixed lifespan (~10 years) ii). Limited partners (LPs) have

Motivational Monday: The Success Story of KIRAN MAZUMDAR-SHAW. This Motivational Monday, we shine a light on the remarkable journey of KIRAN MAZUMDAR-SHAW, the founder of BICON, India’s leading biopharmaceutical company. Kiran's journey started with

Kya aap bhi toh doomscrolling nahi karte??------ . --- Pehle Bookmark then Socho ------->> . Understanding Doomscrolling: Key Facts and Stats 1. What is Doomscrolling? - 📱 Definition: Doomscrolling is the habit of continuously consuming negative

Top News of the Week: 1. Funding: - 25 Indian startups raised around $432 million in funding. These deals count 6 growth-stage deals and 16 early-stage deals while 3 early-stage startups kept their transaction details undisclosed. - On a weekly b

What Seed VCs Really Think (But Don’t Say Out Loud) Ever pitched a VC and heard this? “It’s early for us.” “Great team, but we’re gonna pass for now.” “Keep us updated.” Translation: ❌ You didn’t pass their internal decision tree. Here’s a quick